JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist

45
00.00%

20min DelayMarket to Open Dec 30 15:30 JST

3.90BMarket Cap-2.47P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BrightPath Biotherapeutics Q2 2025 Earnings Date

Currency：JPYNov 8, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
EPS	--	-2.45	--
		+40.41%
NI to Common Holders	--	-208.00M	--
		+19.43%

Analyst Rating

No Data

BrightPath Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

No Data

BrightPath Biotherapeutics Earnings Reports

BrightPath Biotherapeutics: Confirmation letter

Nov 8, 2024 01:35 ET

BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

Nov 8, 2024 01:34 ET

BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

Nov 8, 2024 01:30 ET

BrightPath Biotherapeutics: 1Q financial results briefing for March 2025 [Japan standard] (non-consolidated).

Aug 9, 2024 02:00 ET

Symbol Price % Chg

See the daily top gainer.